Reserve antivirals for pandemic use

Antivirals amantadine (Lysovir or Symmetrel) and rimantadine (Flumadine) should not be used for seasonal flu control because of serious side-effects such as insomnia and hallucinations, according to Italian and Australian researchers.

They advised that zanamivir (Relenza) and oseltamivir (Tamiflu) be used in an epidemic or pandemic scenario.

NICE advises against the use of amantadine but recommends oseltamivir and zanamivir be used if levels of influenza A or B reach more than 50 consultations per 100,000 population in England and Scotland, or more than 25 in Wales.

NICE has not advised on rimantadine use because it is not licensed in the UK.

M2 channel inhibitors amantadine and rimantadine were found to have a symptomatic effect on patients' flu symptoms.

They did not prevent infection or reduce nasal viral shedding.

The neuraminidase inhibitors zanamivir and oseltamivir were found to reduce symptoms. They also reduced transmission of seasonal flu, but did not prevent asymptomatic infection or nasal viral shedding.

The researchers concluded that to prevent resistant flu strains developing, neuraminidase inhibitors should only be used in the event of a serious epidemic or pandemic.

They also reported that there was no credible evidence that oseltamivir could treat avian influenzas, including H5N1.

www.thelancet.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

A day in the life of a prison GP

A day in the life of a prison GP

Dr Patrick Staite tells GP Jobs what it is like to work as a prison GP.

GP practice list size up nearly 50% since 2004 contract

GP practice list size up nearly 50% since 2004 contract

The average GP practice list in England has increased by almost half since the new...

Fresh calls to scrap Capita contract as more cervical screening failures emerge

Fresh calls to scrap Capita contract as more cervical screening failures emerge

The BMA has renewed calls for NHS England to strip Capita of its primary care support...

Cost-effectiveness of GP at Hand 'challenging' to assess, interim report warns

Cost-effectiveness of GP at Hand 'challenging' to assess, interim report warns

The cost-effectiveness of the Babylon GP at Hand service will be difficult to determine...

How we improved end-of-life care in our practice

How we improved end-of-life care in our practice

Dr Victoria Middleton explains how her practice has increased the number of patients...

12,000-patient practice forced to close after service charge hike

12,000-patient practice forced to close after service charge hike

A 12,000-patient GP practice in Nottinghamshire has been forced to hand back its...